Secretaría Xeral Técnica
Administrative center
Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias
Madrid, EspañaPublications in collaboration with researchers from Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (6)
2024
-
Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol
Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1
-
Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study
The Lancet Infectious Diseases, Vol. 24, Núm. 8, pp. 817-828
-
Short- and mid-term morbidity and primary-care burden due to infant respiratory syncytial virus infection: A Spanish 6-year population-based longitudinal study
Pediatric Allergy and Immunology, Vol. 35, Núm. 5
2023
-
COVID-19 vaccine effectiveness in children by age groups. A population-based study in Galicia, Spain
Pediatric Allergy and Immunology, Vol. 34, Núm. 10
2022
-
Effectiveness of COVID-19 vaccine booster in the general population and in subjects with comorbidities. A population-based study in Spain
Environmental Research, Vol. 215
-
Evaluation of BNT162b2 Vaccine Effectiveness in Galicia, Northwest Spain
International Journal of Environmental Research and Public Health, Vol. 19, Núm. 7